StockNews.com assumed coverage on shares of Infinity Pharmaceuticals (NASDAQ:INFI – Get Rating) in a research note published on Thursday. The firm issued a hold rating on the biotechnology company’s stock. Separately, Piper Sandler restated a neutral rating on shares of Infinity Pharmaceuticals in a research report on Friday, February 24th. Infinity Pharmaceuticals Stock Up 32.6 […]
Stock analysts at StockNews.com assumed coverage on shares of Infinity Pharmaceuticals (NASDAQ:INFI – Get Rating) in a research report issued on Thursday. The brokerage set a “hold” rating on the biotechnology company’s stock. Separately, Piper Sandler reissued a “neutral” rating on shares of Infinity Pharmaceuticals in a research note on Friday, February 24th. Infinity Pharmaceuticals […]
StockNews.com initiated coverage on shares of Infinity Pharmaceuticals (NASDAQ:INFI – Get Rating) in a research report report published on Thursday. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, Piper Sandler reiterated a neutral rating on shares of Infinity Pharmaceuticals in a research report on Friday, February 24th. Infinity Pharmaceuticals Price Performance […]
StockNews.com started coverage on shares of Infinity Pharmaceuticals (NASDAQ:INFI – Get Rating) in a research note released on Wednesday. The firm issued a hold rating on the biotechnology company’s stock. Separately, Piper Sandler reiterated a neutral rating on shares of Infinity Pharmaceuticals in a research report on Friday, February 24th. Infinity Pharmaceuticals Trading Down 3.3 […]
StockNews.com began coverage on shares of Infinity Pharmaceuticals (NASDAQ:INFI – Get Rating) in a research note published on Tuesday. The firm issued a hold rating on the biotechnology company’s stock. Separately, Piper Sandler restated a neutral rating on shares of Infinity Pharmaceuticals in a research note on Friday, February 24th. Infinity Pharmaceuticals Stock Performance NASDAQ:INFI […]